Delivery Order 75N94020D00016-75N94023F00001
Award Date
9/28/23
Potential Completion Date
5/31/25
Potential Value
$251K
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
15
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is to the Oregon Health & Science University (OHSU), a prominent research university and academic medical center, to conduct a randomized controlled clinical trial on a female contraceptive. The contract, valued at $619,729.00, was awarded by the U.S. government on April 1, 2004, with a completion date of September 30, 2007. The contract is a delivery order and is classified as cost no fee. OHSU is not a small business set-aside. The contract is part of OHSU's...
This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for the clinical evaluation of novel female contraception products. The contract has a period of performance from November 9, 2015 to November 8, 2018, with an ultimate completion date of September 30, 2022. The contract is a firm fixed price award with a ceiling value of $160,379.14. It does not have a set-aside...
This is a federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) to provide services related to protocol review, protocol development, and activities associated with the NICHD Contraceptive Clinical Trials Network (CCTN). The contract has a ceiling value of $81,367.65 and a period of performance through July 31, 2025. It is a delivery order contract with a cost-no-fee pricing type and...
This federal contract award to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, is for the OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL. The contract has a ceiling value of $87,270.00 and a period of performance through March 28, 2025. It was awarded by the National Institute of Child Health and Human Development, a...
This is a $349,327 delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Essential Access Health, a non-profit organization. The delivery order is for finalizing the protocol, obtaining regulatory approval, and commencing recruitment and enrollment for a clinical trial of the Ovaprene vaginal device. This award is part of a larger $5 million indefinite delivery contract with NICHD to conduct clinical trials and develop protocols...
The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, has awarded a $43,865.00 delivery order contract to The Regents of the University of California, San Francisco (UCSF) for the "OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL." This contract, which does not have a set-aside designation, supports activities...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Emory University, a private non-profit research university, for the OVAPRENE VAGINAL DEVICE CLINICAL TRIAL. The contract has a ceiling value of $100,676.84 and is a Cost Plus Fixed Fee Delivery Order, with a period of performance through August 31, 2025. The contract is not set aside for any specific socioeconomic category. The contract supports the finalization...
This federal contract award, with a ceiling value of $685,003.00, was issued by the National Institute of Child Health and Human Development (NICHD) to Oregon Health & Science University (OHSU) for the "Clinical Evaluation of Long-Acting Reversible Contraceptives." The period of performance is from September 25, 2015 to September 24, 2018, with an ultimate completion date of March 1, 2024. This contract is not designated as a set-aside. OHSU, a prominent research university and...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU), a U.S. state government, educational institution, and state-controlled institution of higher learning. The $133,612.31 contract is for the provision of assistance in protocol review, protocol development, and activities associated with the past, present, and future of the Contraceptive Clinical Trials Network (CCTN)...
The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, has awarded a $141,890 cost-plus-fixed-fee delivery order contract to the University of Utah's Office of Sponsored Projects Division. The contract is for the finalization of the protocol, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the Ovaprene vaginal device clinical trial. The contract has an ultimate completion date of December 31, 2025. The...